Story Poster
Photo by Barbara J. Perenic | USA Today
Notre Dame Football

Coach | Notre Dame Adding Jean-Baptiste Is A "Win-Win"

January 13, 2023
5,905

Notre Dame’s addition of Javontae Jean-Baptiste is a phenomenal fit for both sides, according to Vito Campanile.

The 6-foot-5, 255-pound Jean-Baptiste just announced he would transfer to Notre Dame after spending five seasons at Ohio State.

“I think it’s just a win-win,” says Campanile, who coached Jean-Baptiste at Bergen Catholic High School in New Jersey. “He’s a kid with an unbelievable work ethic.

“For him, it’ll really help him for the next level. For Notre Dame, I think they’re just going to get a winner in every way. He checks every box with what Notre Dame looks for in their players. You know how I feel about their program. I think they do an unbelievable job developing people. I think they have a really good thing in place. It is.”

Campanile expects Jean-Baptiste to have a huge impact on the Irish’s defense in 2023.

“He’s going to be an unbelievable pass rusher,” the coach says. “I think he’s just got a winning pedigree. He’s got a championship mentality, unbelievable character kid. He’s going to bring length and incredible effort.”

Irish defensive line coach Al Washington was on staff at Ohio State for three years while Jean-Baptiste was a Buckeye, which provided some additional familiarity in the process.

“The guys have done a really good job with him,” Campanile says. “Coach Wash has a relationship with him. I think he feels really comfortable with that.”

Campanile believes Jean-Baptiste playing final season of college ball in South Bend with Washington and defensive coordinator Al Washington will only enhance Jean-Baptiste’s draft stock in a year.

“They will develop him for the next level. The fact that Coach Golden has spent so much time in the NFL, that can only help you.”

Vineyard Vines Gray Notre Dame Sankaty Quarter-Zip Sweatshirt ($139.99)

 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.